$REGN:NASDAQ - REGENERON PHARMACEUTICALS

Regeneron has been having a nice run since the end of last year and is up around 100%. Financials look pretty strong. Could be worth a watch.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP.

Commentaire:

Hasn't done much. Small gain, but the volume over the last few days has been interesting. Have set an alert to have another look if it moves above $590.

Commentaire:

Nice explosive move out of its channel.